Dealing with dermatomyositis just got a whole lot less prickly. The FDA officially approved the first-ever pill for the condition, so patients can finally ditch the needles for a simple daily dose. It is a massive win for managing those tough skin flares and muscle weakness. Science for the win! 💊✨
👇 Check it out:
MedPage Today
Medpage Today
First Oral Option for Dermatomyositis Gets FDA Green Light
Brepocitinib significantly improved overall symptom status in a phase III trial
August 28, 2026 2
